Dandan Zhai

Hefei, 230000, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Research progress of CD73-adenosine signaling regulating hepatocellular carcinoma through tumor microenvironment.

Research progress of CD73-adenosine signaling regulating hepatocellular carcinoma through tumor microenvironment.

Journal: Journal of experimental & clinical cancer research : CR

Published: January 17, 2025

Kasai Portoenterostomy, Successful Liver Transplantation, and Immunosuppressive Therapy for Biliary Atresia in a Female Baby: A Case Report.

Kasai Portoenterostomy, Successful Liver Transplantation, and Immunosuppressive Therapy for Biliary Atresia in a Female Baby: A Case Report.

Journal: Journal of inflammation research

Published: August 23, 2023

Caffeine in Hepatocellular Carcinoma: Cellular Assays, Animal Experiments, and Epidemiological Investigation.

Caffeine in Hepatocellular Carcinoma: Cellular Assays, Animal Experiments, and Epidemiological Investigation.

Journal: Journal of inflammation research

Published: June 05, 2023

Corrigendum to: "Matrix metalloproteinases induce extracellular matrix degradation through various pathways to alleviate hepatic fibrosis", [Biomed. Pharmacother., 161; (2023): 114472].

Corrigendum to: "Matrix metalloproteinases induce extracellular matrix degradation through various pathways to alleviate hepatic fibrosis", [Biomed. Pharmacother., 161; (2023): 114472].

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: April 02, 2023

New insights into fibrotic signaling in hepatocellular carcinoma.

New insights into fibrotic signaling in hepatocellular carcinoma.

Journal: Frontiers in oncology

Published: March 29, 2023

Matrix metalloproteinases induce extracellular matrix degradation through various pathways to alleviate hepatic fibrosis.

Matrix metalloproteinases induce extracellular matrix degradation through various pathways to alleviate hepatic fibrosis.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: December 27, 2022

Caffeine in liver diseases: Pharmacology and toxicology.

Caffeine in liver diseases: Pharmacology and toxicology.

Journal: Frontiers in pharmacology

Published: August 28, 2022

New Drugs for Hepatic Fibrosis.

New Drugs for Hepatic Fibrosis.

Journal: Frontiers in pharmacology

Published: February 12, 2022

Curcumin-loaded nanostructured lipid carrier induced apoptosis in human HepG2 cells through activation of the DR5/caspase-mediated extrinsic apoptosis pathway.

Curcumin-loaded nanostructured lipid carrier induced apoptosis in human HepG2 cells through activation of the DR5/caspase-mediated extrinsic apoptosis pathway.

Journal: Acta pharmaceutica (Zagreb, Croatia)

Published: April 19, 2019

Pharmacokinetic studies and anticancer activity of curcumin-loaded nanostructured lipid carriers.

Pharmacokinetic studies and anticancer activity of curcumin-loaded nanostructured lipid carriers.

Journal: Acta pharmaceutica (Zagreb, Croatia)

Published: March 19, 2017

The role of the vascular endothelial growth factor/vascular endothelial growth factor receptors axis mediated angiogenesis in curcumin-loaded nanostructured lipid carriers induced human HepG2 cells apoptosis.

The role of the vascular endothelial growth factor/vascular endothelial growth factor receptors axis mediated angiogenesis in curcumin-loaded nanostructured lipid carriers induced human HepG2 cells apoptosis.

Journal: Journal of cancer research and therapeutics

Published: October 14, 2015

Showing 1-11 of 11

Last Updated: 09/26/2026